Charles Ryhee

Stock Analyst at TD Cowen

(2.45)
# 2,487
Out of 4,996 analysts
17
Total ratings
60%
Success rate
10.62%
Average return

Stocks Rated by Charles Ryhee

CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73$80
Current: $75.77
Upside: +5.58%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563$652
Current: $760.55
Upside: -14.27%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185$170
Current: $160.16
Upside: +6.14%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57$59
Current: $8.95
Upside: +559.22%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59$72
Current: $153.71
Upside: -53.16%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240$188
Current: $8.16
Upside: +2,203.92%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $18.42
Upside: +57.44%